Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

ClinicalTrials.gov ID: NCT07671911

Public ClinicalTrials.gov record NCT07671911. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 7, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nalbuphine Extended-Release Tablets for the Treatment of Chronic Cough in Participants With Idiopathic Pulmonary Fibrosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose is to evaluate the safety and efficacy of NAL ER for the treatment of chronic cough in participants with Idiopathic Pulmonary Fibrosis (IPF).

Study identification

NCT ID: NCT07671911
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Trevi Therapeutics; Industry
Enrollment: 306 participants

Conditions and interventions

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

NAL ER Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 40 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 28, 2026
Primary completion: May 31, 2028
Completion: Jun 30, 2028
Last update posted: Aug 30, 2026

2026 – 2028

United States locations

U.S. sites: 15
U.S. states: 8
U.S. cities: 15

Facility	City	State	ZIP	Site status
Newportnativemd, Inc.	Newport Beach	California	92663-3600	Recruiting
Palmtree Clinical Research	Palm Springs	California	92262	Recruiting
Paradigm Clinical Research Centers, Inc. - Redding	Redding	California	96001	Recruiting
Critical Care Pulmonary and Sleep Associates (Ccpsa) - West Clinic	Lakewood	Colorado	80228	Recruiting
Meris Clinical Research	Brandon	Florida	33511	Recruiting
Pulmonary Specialists of The Palm Beaches	Loxahatchee Groves	Florida	33470	Recruiting
Clinical Research and Associates, Inc.	Miami	Florida	33126	Recruiting
Coastal Pulmonary & Critical Care, PLC	St. Petersburg	Florida	33704-2733	Recruiting
Hannibal Regional Hospital	Hannibal	Missouri	63401	Recruiting
Clinical Research of Gastonia (CRG)	Gastonia	North Carolina	28054	Recruiting
Clinical Research Associates of Central, PA, LLC	DuBois	Pennsylvania	15801	Recruiting
Anmed Medical Center	Anderson	South Carolina	29621	Recruiting
Horizon Clinical Research Group	Cypress	Texas	77429	Recruiting
El Paso Pulmonary Association, PA	El Paso	Texas	79902	Recruiting
Elevate Clinical Research	Houston	Texas	77058	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07671911, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 30, 2026 · Synced Sep 7, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07671911 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →